Running summarizing tools on a new article
Check the paper below, then start its synthesis.
1523P Gut microbiome composition associates with clinical response to immune checkpoint inhibitor (ICI) therapy across multiple patient cohorts
Pippa G. Corrie (Cambridge University Hospitals NHS Foundation Trust), Brent O’Carrigan (Cambridge University Hospitals NHS Foundation Trust), Kate M. Fife (Cambridge University Hospitals NHS Foundation Trust), H. Winter (University Hospitals Bristol and Weston NHS Foundation Trust), Matthew James Wheater (University Hospital Southampton NHS Foundation Trust), Tania Tillett (Royal United Hospital, Royal United Hospital Bath NHS Trust), Guy E.S. Faust (University Hospitals of Leicester NHS Trust), Ewan R. Brown (NHS Lothian), T. Geldart (Poole Hospital, University Hospitals Dorset NHS Foundation Trust), C. Barlow (Taunton & Somerset NHS Foundation Trust, Somerset NHS Foundation Trust), T. Talbot (Royal Cornwall Hospital Trust, Royal Cornwall Hospital), Jenny Penelope Nobes (Norfolk and Norwich University Hospital, Norfolk and Norwich University Hospitals NHS Foundation Trust), Sarah J. Danson (Sheffield Teaching Hospitals NHS Foundation Trust, University of Sheffield), Ricky Dylan Frazer (Velindre NHS Trust, Velindre Cancer Centre), Andrew M. C. Thomas, V. Fairclough, Nikolaos Demiris (Cambridge Clinical Trials Unit), Grant Duncan Stewart (University of Cambridge), Matthew J. Robinson, Trevor D. Lawley